Old Web
English
Sign In
Acemap
>
authorDetail
>
Karen Cheng
Karen Cheng
Boehringer Ingelheim
Internal medicine
Medicine
Placebo
Diabetes mellitus
Linagliptin
3
Papers
58
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P319 Tolérance de la linagliptine chez 8 778 patients diabétiques de type 2 (DT2): analyse des données regroupées de 23 études cliniques randomisées et contrôlées par placebo
2015
Diabetes & Metabolism
Guntram Schernthaner
Kamlesh Khunti
S. Patel
Karen Cheng
Michaela Mattheus
D. Clark
Show All
Source
Cite
Save
Citations (0)
Safety of Linagliptin in 8778 Patients With Type 2 Diabetes Mellitus: Pooled Analysis of 23 Placebo-Controlled Randomized Clinical Trials
2014
Canadian Journal of Diabetes
Guntram Schernthaner
Kamlesh Khunti
Sanjay R. Patel
Karen Cheng
Michaela Mattheus
Hans J. Woerle
Show All
Source
Cite
Save
Citations (1)
Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies.
2014
Clinical Therapeutics
Michael Lehrke
Nikolaus Marx
Sanjay Patel
Thomas Seck
Susanne Crowe
Karen Cheng
Maximilian von Eynatten
Odd Erik Johansen
Show All
Source
Cite
Save
Citations (57)
1